Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
410 Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
410 Medical

410 Medical

Series B

410 Medical, Inc. provides rapid infusion systems for critical care in North Carolina hospitals.

HQ
Durham, NC, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

410 Medical, founded with the mission to enhance resuscitation through earlier and controlled fluid delivery, focuses on providing innovative medical devices to healthcare providers. Their flagship product, LifeFlow PLUS, is a hand-operated rapid infuser designed to quickly deliver blood or fluids to critically ill patients in need of volume resuscitation. The company primarily serves hospitals and healthcare providers in North Carolina, aiming to improve outcomes for patients experiencing severe conditions such as septic shock.

Notable figures affiliated with 410 Medical include healthcare professionals and investors dedicated to advancing critical care technologies. The company has achieved significant milestones, including the successful implementation of LifeFlow PLUS in various medical settings, positively impacting patient recovery rates. By addressing a critical need in emergency and intensive care, 410 Medical has established itself as a key player in the medical device industry, contributing to improved patient care and outcomes.

410 Medical - Similar Companies

Optivia logo

Optivia

Infused Medical Technology logo

Infused Medical Technology

Liquet Medical logo

Liquet Medical

liquetmedical.com

Velosal Medical logo

Velosal Medical

EndoShunt Medical logo

EndoShunt Medical

endoshunt.com

Innovative Trauma Care logo

Innovative Trauma Care

Flow Medical logo

Flow Medical

flowmedical.co

Ativa Medical logo

Ativa Medical

Compact Medical logo

Compact Medical

Anutra Medical logo

Anutra Medical

ICU Medical logo

ICU Medical

icumed.com

Axe Compute logo

Axe Compute

Proa Medical logo

Proa Medical

proamedical.com

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

Akros Medical logo

Akros Medical

410 Medical - Quick Facts

Who are 410 Medical's competitors?

Companies similar to 410 Medical include Optivia, Infused Medical Technology, Liquet Medical and Velosal Medical.

When was 410 Medical founded?

410 Medical was founded in 2013.

Where is 410 Medical's headquarters located?

410 Medical's headquarters is located in Durham, NC, US.

When was 410 Medical's last funding round?

410 Medical's most recent funding round was for $7.5M (USD) in May 2023.

How much has 410 Medical raised to-date?

As of May 25, 2023, 410 Medical has raised a total of $38.2M (USD).

How many employees does 410 Medical have?

410 Medical has 35 employees as of Feb 5, 2024.

410 Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
  • Medical
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies